Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:


A small molecule kicks repeat expansion into reverse

Huntington’s disease is a severe progressive neurological disorder caused by a CAG-repeat expansion in the HTT gene. A small molecule shows therapeutic potential by inducing contraction of these expanded CAG repeats in cell and mouse models of the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: NA induces contraction of CAG repeats in a mouse model of HD.


  1. Neil, A. J., Kim, J. C. & Mirkin, S. M. BioEssays 39, 1700077 (2017).

    Article  Google Scholar 

  2. Kennedy, L. et al. Hum. Mol. Genet. 12, 3359–3367 (2003).

    Article  CAS  Google Scholar 

  3. Thornton, C. A., Johnson, K. & Moxley, R. T. III Ann. Neurol. 35, 104–107 (1994).

    Article  CAS  Google Scholar 

  4. Ciosi, M. et al. EBioMedicine 48, 568–580 (2019).

    Article  Google Scholar 

  5. Pinto, R. M. et al. PLoS Genet. 9, e1003930 (2013).

    Article  Google Scholar 

  6. Dragileva, E. et al. Neurobiol. Dis. 33, 37–47 (2009).

    Article  CAS  Google Scholar 

  7. Tomé, S. et al. PLoS Genet. 9, e1003280 (2013).

    Article  Google Scholar 

  8. Nakatani, R., Nakamori, M., Fujimura, H., Mochizuki, H. & Takahashi, M. P. Sci. Rep. 5, 11020 (2015).

    Article  CAS  Google Scholar 

  9. Bourn, R. L. et al. PLoS One 7, e47085 (2012).

    Article  CAS  Google Scholar 

  10. Zhao, X. N. et al. Hum. Mol. Genet. 24, 7087–7096 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. Cell 162, 516–526 (2015).

    Article  Google Scholar 

  12. Lee, J. M. et al. Hum. Mol. Genet. 26, 3859–3867 (2017).

    Article  CAS  Google Scholar 

  13. Moss, D. J. H. et al. Lancet Neurol. 16, 701–711 (2017).

    Article  CAS  Google Scholar 

  14. Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. CAG repeat not polyglutamine length determines timing of Huntington’s Disease onset. Cell 178, 887–900.e14.

  15. Bettencourt, C. et al. Ann. Neurol. 79, 983–990 (2016).

    Article  CAS  Google Scholar 

  16. Nakamori, M. et al. Nat. Genet. (2020).

  17. Hagihara, M. & Nakatani, K. Nucleic Acids Symp. Ser. (Oxf.) 50, 147–148 (2006).

    Article  Google Scholar 

  18. Axford, M. M. et al. PLoS Genet. 9, e1003866 (2013).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Sarah J. Tabrizi.

Ethics declarations

Competing interests

M.D.F. has no competing interests. S.J.T. is on scientific advisory boards for Triplet Therapeutics and LoQus therapeutics and has laboratory funding from Vertex pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Flower, M.D., Tabrizi, S.J. A small molecule kicks repeat expansion into reverse. Nat Genet 52, 136–137 (2020).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing